|Articles|July 22, 2015

WHO Issues Policy Brief on HIV Prevention Among Transgender Populations

This new technical brief summarizes essential information and existing World Health Organization (WHO) recommendations for HIV prevention, diagnosis, treatment and care among transgender populations.

The 2011 WHO guidance, Prevention and Treatment of HIV and Other Sexually Transmitted Infections Among Men Who Have Sex With Men and Transgender People, did not separate recommendations for transgender people from those for men who have sex with men. The 2014 WHO Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations acknowledge that the “high vulnerability and specific health needs of transgender people necessitates a distinct and independent status in the global HIV response” and consider transgender people as a separate key population. However, to date, no global WHO document has addressed these needs exclusively. To fill that gap, this technical brief highlights WHO recommendations on HIV prevention, diagnosis, treatment care and needs of transgender people.

Source: WHO


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.